SLEEP, Vol. 31, No. 8, 2008 1068 death rates in patients with severe OSA on CPAP
treatment are not different than controls or snorers without OSA and with similar degrees of …

The association of obstructive sleep apnea (OSA) with vascular disease and mortality was
reported in clinical case series almost 3 decades ago and has since been confirmed in …

Background. airway pressure (CPAP) has been shown to be an effective treatment for
reducing this excess of mortality. However, the vast majority of studies have been performed …

He et al. indicated that mortality is reduced in treated patients with OSA but the reasons for
this are still speculative. CPAP eliminates the acute elevation of blood pressure (BP) that …

Understanding the cardiovascular (CV) impact of obstructive sleep apnea (OSA) is now a
mature research field. After more than four decades of experimental, translational, and …

The mortality and morbidity associated with OSA are reduced in patients well managed with
PAP. However, we await the results of large randomized clinical trials to definitely determine …

Three recent randomized control trials (RCTs) found that treatment of obstructive sleep
apnea (OSA) with continuous positive airway pressure (CPAP) did not reduce rates of future …

Obstructive sleep apnea (OSA) is a common disease characterized by recurrent upper
airway obstruction, intermittent hypoxemia and sleep fragmentation. OSA is considered to be …

Obstructive sleep apnea (OSA) is associated with increased cardiovascular risk, mediated
through pathophysiological mechanisms that include intermittent hypoxia, excessive …

Objective Most studies have used cardiovascular and cerebrovascular disease (CVD) end-
points to measure the effect of continuous positive airway pressure (CPAP), but pre …